Entero Therapeutics, Inc. Annual Operating Income (Loss) in USD from 2015 to 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Entero Therapeutics, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2015 to 2024.
  • Entero Therapeutics, Inc. Operating Income (Loss) for the quarter ending December 31, 2024 was -$1.08M, a 73.7% increase year-over-year.
  • Entero Therapeutics, Inc. Operating Income (Loss) for the twelve months ending December 31, 2024 was -$15.6M, a 0.95% increase year-over-year.
  • Entero Therapeutics, Inc. annual Operating Income (Loss) for 2024 was -$15.6M, a 0.95% increase from 2023.
  • Entero Therapeutics, Inc. annual Operating Income (Loss) for 2023 was -$15.8M, a 24.4% decline from 2022.
  • Entero Therapeutics, Inc. annual Operating Income (Loss) for 2022 was -$12.7M, a 78.5% increase from 2021.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$15.6M +$150K +0.95% Jan 1, 2024 Dec 31, 2024 10-K/A 2025-04-09
2023 -$15.8M -$3.09M -24.4% Jan 1, 2023 Dec 31, 2023 10-K/A 2025-04-09
2022 -$12.7M +$46.4M +78.5% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-29
2021 -$59.1M -$32.6M -123% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-20
2020 -$26.4M -$11.7M -79.3% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-31
2019 -$14.7M -$1.31M -9.77% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-31
2018 -$13.4M -$3.21M -31.4% Jan 1, 2018 Dec 31, 2018 10-K 2019-04-01
2017 -$10.2M -$3.9M -61.6% Jan 1, 2017 Dec 31, 2017 10-K 2019-04-01
2016 -$6.33M -$1.6M -33.8% Jan 1, 2016 Dec 31, 2016 10-K 2018-03-16
2015 -$4.73M Jan 1, 2015 Dec 31, 2015 10-K 2017-03-31
* An asterisk sign (*) next to the value indicates that the value is likely invalid.